Sting Operation Exposes Gaps in Oversight of Human Experiments

March 27, 2009

Thousands of medical research groups that monitor clinical trials on behalf of the drug industry may face tougher regulations in the wake of a congressional sting operation that found gaps in the nation’s oversight of experiments on humans. (Wall Street Journal)